PD Active Forum - Saturday, September 8th, 10:30 a.m. - 12:30 p.m.
Our next Forum speaker, Coralie de Hemptinne, will be presenting on the clinical trials being conducted by the Starr Lab at UCSF.
Currently, Coralie works as an associate researcher at the Starr Lab, in the Department of Neurological surgery at UCSF. The aim of her research is to understand the pathophysiology underlying motor and non-motor symptoms in Parkinsons disease patients, and use pathological signals to inform new therapies for the disease. Together with her colleagues at the Starr Lab, she has helped to pioneer the development and implementation of the first closed-loop algorithms to trigger stimulation based on cortical biomarker detection for PD.
Deep brain stimulation (DBS) is a common treatment for movement disorders that consists in delivering continuous electrical stimulation in deep brain structures. Although increasingly used, DBS has several limitations. Namely, existing DBS devices continuously stimulate their target structures regardless of patient's symptoms, resulting in habituation (less efficacy), stimulation-induced adverse effects, and short battery life. The goal of UCSF's trials is to improve DBS therapy by developing smart DBS paradigms able to automatically adjust stimulation parameters based on the patients symptoms.
Berkeley Unitarian Fellowship Hall (View)
1924 Cedar Street
Berkeley, CA 94709
|Kid Friendly: No|
|Dog Friendly: No|
|Wheelchair Accessible: Yes!|